Objective: We performed a cross-disciplinary review of the effects of multipollutant exposures on cardiovascular effects. Methods: A broad literature search for references including at least two criteria air pollutants (particulate matter [PM], ozone [O 3 ], oxides of nitrogen, sulfur oxides, carbon monoxide) was conducted. References were culled based on scientific discipline then searched for terms related to cardiovascular disease. Most multipollutant epidemiologic and experimental (i.e., controlled human exposure, animal toxicology) studies examined PM and O 3 together. Discussion: Epidemiologic and experimental studies provide some evidence for O 3 concentration modifying the effect of PM, although PM did not modify O 3 risk estimates. Experimental studies of combined exposure to PM and O 3 provided evidence for additivity, synergism, and/or antagonism depending on the specific health endpoint. Evidence for other pollutant pairs was more limited. Conclusions: Overall, the evidence for multipollutant effects was often heterogeneous, and the limited number of studies inhibited making a conclusion about the nature of the relationship between pollutant combinations and cardiovascular disease.
Introduction
Under the Clean Air Act, EPA regulates six criteria pollutants [particulate matter (PM), ozone (O 3 ), nitrogen dioxide (NO 2 ), sulfur dioxide (SO 2 ), carbon monoxide (CO), and lead (Pb)] individually. Implementation of the National Ambient Air Quality Standards (NAAQS) has reduced annual average concentrations of criteria air pollutants by 28-87% from 1980 to 2013 (U.S. EPA, 2016b (U.S. EPA, , 2017 . However, several research groups have commented that single-pollutant regulation is inefficient because multiple pollutants often have common sources and individuals are not exposed to only one pollutant at a time (Dominici et al., 2010; Greenbaum and Shaikh, 2010; Hidy and Pennell, 2010; Johns et al., 2012; Mauderly et al., 2010; NRC, 2004) . Generally speaking, a multipollutant regulatory approach might focus on how different air pollutant mixtures contribute to populationlevel exposures and identify which mixtures are most closely associated with particular health outcomes. Once relevant mixtures are identified, regulators could focus on the sources of those mixtures, transport and transformation of emissions from those sources, and relevant population exposures to those mixtures. While this approach is certainly complex, it will be more efficient by allowing for regulatory assessments to be conducted for a subset of relevant mixtures. For example, a case study that modeled scenarios to quantify health impacts of air pollution management strategies found larger reductions in both pollutant concentrations and cases of premature mortality attributable to PM with aerodynamic diameter ≤ 2.5 µm (PM 2.5 ) or O 3 exposure for multipollutant emission control strategies than for single-pollutant control strategies (i.e., reductions were greater than additive) (Wesson et al., 2010) .
There are also uncertainties related to evaluating one air pollutant at a time, which may be one reason for the growing interest in health effects of multipollutant exposures in both epidemiologic and experimental (i.e., controlled human exposure, animal toxicological) studies. Epidemiologic studies may statistically adjust for the association of another air pollutant in multivariable copollutant models to discern a potential independent association for a single pollutant. However, inferences from such analyses may be uncertain as effect estimates can be inflated for pollutants measured with less error or can be unreliable if copollutants are highly correlated (Zeger et al., 2000) . Single-pollutant analyses do not account for the possibility that exposure to multiple pollutants may have effects that are other than additive, (i.e., the combined influence of multiple pollutants represented by the sum of their independent effects). While multipollutant analyses do not reduce or eliminate residual confounding or the impacts of measurement error commonly attributed to single-pollutant models, they allow for examination of the combined influence of multiple pollutants.
Several statistical methods have been applied or are being developed to examine the relationship between multipollutant exposures and health effects (Billionnet et al., 2012; Davalos et al., 2016) . To date, experimental studies have evaluated interactions, effects of simultaneous exposure to two or more pollutants that differ from the summed effect of each exposure occurring alone (Vanderweele, 2009 ). These interaction effects may be antagonistic, an effect of simultaneous exposure to two or more pollutants that is lower in magnitude than the sum of the effect of the individual pollutants, or synergistic, an effect of simultaneous exposure to two or more pollutants that is greater than the sum of the effect of the individual pollutants (Mauderly, 1993; Mauderly and Samet, 2009) . In epidemiologic studies, various multipollutant regression techniques are available to estimate joint effects by including additive or multiplicative interaction terms in the regression model. For example, Winquist et al. (2014) assessed the joint effect of combinations of air pollutants for asthma emergency department visits by calculating the effect of a specified change in each pollutant in the combination. Epidemiologic and experimental studies have also examined effect measure modification, where the effect of one pollutant varies by level of another (Howe et al., 2012; Vanderweele, 2009) .
The objective of this review was to perform a cross-disciplinary evaluation of the multipollutant effects on health endpoints related to cardiovascular disease (CVD). In other words, the review entails integration of results from observational epidemiologic studies with experimental controlled human exposure and animal toxicological studies. The cross-disciplinary nature of this review allows us to integrate across the continuum of CVD endpoints, from biomarkers of inflammation and coagulation, sub-clinical markers of CVD, clinical endpoints including hospital admission and emergency department visits, and mortality, and aids in reducing uncertainties related to potential confounding, exposure misclassification, and differences across animal species that would be present if the review were limited to one scientific discipline. In this review, multipollutant effects were specified to include at least two criteria air pollutants evaluated for interactions (in experimental studies), joint effects (in epidemiologic studies), or effect measure modification (in experimental or epidemiologic studies). We identified studies reporting interactions, joint effects, and effect measure modification (which include data on concentrations of individual criteria air pollutants) which are more informative of multipollutant effects than studies of clusters, indices and whole atmosphere exposures, where information on concentrations of individual criteria pollutants are often not available. To be complete, we discuss studies of cluster, indices and whole atmosphere exposures in Section 3.7. We assessed the coherence of results from epidemiologic and experimental studies to strengthen inference about health effects due to multipollutant exposures.
Methods
We identified studies on multipollutant exposures and CVD-related effects published through December 31, 2015 using a stepwise systematic literature search that employed Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines as illustrated in Fig. 1 and described in detail in the Supplemental Materials. The literature review began with a broad literature search for references including at least two criteria air pollutants among PM, O 3 , oxides of nitrogen (NO X ), sulfur oxides (SO X ), and CO using an array of search terms (Supplemental Tables S1 and S2). The retrieved references were refined by applying an automatic topic classification algorithm to segregate references into epidemiologic or experimental study domains. The algorithm, trained by a set of known relevant seed references, had recall greater than 90% but lower precision (Supplemental Tables S3  and S4 ), meaning the bins captured most of the relevant references for the intended domain but also captured many references from other domains. Next, specific terms related to CVD (identified from (Gill et al., 2011) ) were applied to the domain-specific bins (Supplemental Table S5 ). From those results, irrelevant references (i.e., non-criteria pollutants and non-CVD-related health effects) were excluded based on manually screening the title and, if necessary, reviewing the abstract. If we could not conclusively determine whether inclusion criteria were T.J. Luben et al. Environmental Research 161 (2018) 144-152 met from reviewing an abstract, we reviewed the reference's methods section. Epidemiologic studies were required to examine joint effects or effect measure modification for CVD in order to be included. Experimental studies were included if they examined CVD effects of (1) an individual air pollutant, (2) co-exposure to one or more additional air pollutants; and (3) a filtered air control in order to examine interactions or effect measure modification. Both simultaneous and sequential co-exposure scenarios were considered relevant. From this process, we identified 31 relevant epidemiologic studies and 15 relevant experimental studies. Studies meeting inclusion criteria were evaluated for risk of bias in results and study design. Risk of bias evaluations assess some aspects of internal validity of study findings based on study design, conduct, and reporting, and can identify potential issues associated with chance, confounding, and other biases. The risk of bias evaluation is a way to characterize potential strengths and weaknesses of individual studies more transparently, and to characterize the body of evidence on which conclusions from this review will be based. Published sources on systematic review were considered when developing a risk of bias framework for use in this review (AHRQ, 2012; Higgins and Green, 2011) . Epidemiologic studies were evaluated for evidence of risk of bias by answering six questions related to confounding bias, exposure misclassification, selection bias, detection bias, disease misclassification, and selective reporting. Controlled human exposure and animal toxicological studies were evaluated for evidence of risk of bias by answering six questions related to confounding bias, performance bias, selection bias, appropriate controls, detection bias and selective reporting. Specifically, we examined the extent to which potential confounders were accounted for in the study population, study design and exposure assessment, whether monitoring techniques were appropriate for the sample population, whether study sampling techniques were clearly described and included subject attrition, the extent to which study conditions were identical across study groups, whether research staff were blinded to exposure status, our confidence in the disease status of subjects reported in the studies, and whether all results were reported. In evaluating these six factors for risk of bias in each study, we assigned a "low", "probably low", "probably high", or "high" risk of bias rating for each factor based on the answer to the question. The results of the risk of bias evaluation are presented in Fig. 2 and additional information is provided in Supplemental Tables S6 and S7 regarding these biases, criteria for assigning a risk of bias category. These criteria are based on the National Toxicology Program's Office of Health Assessment and Translation risk-of-bias tool described in Rooney et al. (2014) and modified slightly to focus on aspects related to populationbased epidemiologic and experimental health studies.
We evaluated and characterized each pair-wise interaction or joint effect available for criteria pollutants in the studies identified by the literature search. Among epidemiologic studies, short-term exposure periods (i.e., hours to weeks) and long-term exposure periods (i.e., months to years) were evaluated separately. Experimental studies mainly evaluated short-term exposure periods of either a few hours or a few days. However, one study involved a subchronic exposure period of several months. The results of epidemiologic and experimental studies were integrated for each possible combination of criteria pollutants included in the identified studies.
Results and discussion
The 31 epidemiologic and 15 experimental studies that met our inclusion criteria are listed by the pollutant combination(s) they examine in Table 1 . Detailed study characteristics and results were extracted from each study and can be found in Tables S8 and S9 for epidemiologic and experimental studies, respectively. We provide broad overviews of the synthesized and integrated evidence for pollutant pairs and air pollutant mixtures in the following sections.
Particulate matter and ozone
Among the relevant multipollutant exposure studies, most examined short-term exposures to PM and O 3. In additional to evaluating multipollutant exposures, these studies often provide evidence that CVD effects are independently related to exposure to PM or O 3 in single pollutant models. Given the evidence for an independent effect of both PM and O3 exposures on CVD endpoints, it is plausible that PM and O 3 could influence each other's effects. However, the U.S. EPA noted consistent evidence for O 3 -associated CVD mortality but inconsistency for O 3 -associated CVD morbidity indicated by hospital admissions, emergency department visits, and blood pressure changes. This may complicate interpretation of the results for PM-O 3 multipollutant effects. There are a few studies of long-term multipollutant PM and O 3 exposure. While there is ample evidence supporting a relationship between CVD effects and long-term PM 2.5 exposure (U.S. EPA, 2009), there is relative uncertainty in the evidence for a relationship with longterm O 3 exposure (U.S. EPA, 2009 (U.S. EPA, , 2013 .
Generally, studies of multipollutant exposure to PM and O 3 report heterogeneous results and do not demonstrate coherence across scientific disciplines, CVD health effects, or time periods of exposure. Across epidemiologic studies, the CVD events included measures of blood pressure, heart-rate variability (HRV), microvascular changes, and hospital admissions or mortality due to cardiovascular conditions. Experimental studies conducted in humans and animals evaluated several non-specific markers and early biological effects (e.g., heart rate, HRV, myocardial repolarization, arterial elastance) that may or may not lead to the type of CVD events evaluated in epidemiologic studies. Results of experimental studies demonstrated synergistic, antagonistic, or no overall interactive effect of PM and O 3 when evaluated on an additive scale. Several studies were conducted in human subjects using essentially the same study design involving a 2-h exposure to PM 2.5 CAPs (concentrated ambient particles) which were collected in Toronto. Acute exposure to PM+O 3 had a synergistic effect on diastolic blood pressure in one study (Fakhri et al., 2009) but not in another (Brook et al., 2009) . Results suggested antagonism for a measure of parasympathetic tone (Fakhri et al., 2009) , and synergism for two measures of myocardial repolarization (Sivagangabalan et al., 2011) . The other experimental studies were conducted in healthy animals or animal models of disease, and involved acute or subchronic exposure to CAPs, diesel exhaust particles and carbon black. They provide evidence for both synergistic and antagonistic effects on blood pressure, myocardial repolarization, cardiac function, and expression of aortic genes (Farraj et al., 2015; Kurhanewicz et al., 2014; Wagner et al., 2014; Tankersley et al., 2013; Kodavanti et al., 2011) . Although no consistent pattern of results emerges from these experimental studies in humans and animals, it is not unexpected given the differences in endpoints examined and/or differences in study design. Similarly, epidemiologic studies of joint effects for both short-and long-term exposure to PM and O 3 do not provide evidence for a greater combined effect (Bob et al., 2013; Kalantzi et al., 2011; Crouse et al., 2015; Jerrett et al., 2013) . While epidemiologic studies do not provide clear evidence of joint effects, there is some evidence for effect measure modification. Three epidemiologic studies observed larger risk estimates for PM with aerodynamic diameter ≤ 10 µm (PM 10 ) when O 3 concentrations were higher. Conversely, experimental studies show that O 3 exposure dampened the effects of PM on IL-6 and on a measure of HRV (Fakhri et al., 2009; Urch et al., 2010) . Risk estimates for CVD hospital admissions or mortality and exposure to O 3 are not consistently modified by PM concentration (Hong et al., 2002; Wong et al., 1999; Ponka et al., 1998) . In contrast, Weichenthal et al. (2014) observed that personal exposure to O 3 had larger associations with HRV on days with higher PM 2.5 concentrations.
The body of evidence available to evaluate the effects of multipollutant exposure to PM and O 3 on CVD effects has several limitations. Epidemiologic studies often estimate PM exposure by ambient PM 10 or T.J. Luben et al. Environmental Research 161 (2018) 144-152 Fig. 2 . Risk of bias evaluation for (A) epidemiologic studies and (B) experimental studies.
T.J. Luben et al. Environmental Research 161 (2018) 144-152 PM 2.5 concentrations, while experimental studies often use surrogates (e.g., CAPs, diesel exhaust particles, carbon black) for exposure to ambient PM. The variability in the size fraction/composition of PM used in these studies may explain some of the heterogeneity in the results. Similarly, the wide range of CVD effects evaluated in this limited number of studies (biomarkers, subclinical effects, counts of hospital admissions, and mortality due to any CVD) and differences in whether healthy animals or animal models of disease were used in experimental studies, make it difficult to assess coherence for any period of exposure (e.g., short-term, subchronic, long-term) or specific CVD effect and to reconcile evidence for early biologic effects that could lead to more severe CVD effects.
Particulate matter and carbon monoxide
Few studies examined multipollutant effects of PM and CO. The ability of short-term CO and PM 2.5 exposure to lead to CVD outcomes is well-established (U.S. EPA, 2010). As described below and examined in epidemiologic and experimental studies, multipollutant effects are not clearly indicated for CO with PM 2.5 or PM 10 .
In a rat model of myocardial infarction, acute exposure to PM 2.5 CAPs collected in Boston, MA had opposite effects on two separate arrhythmic responses (Wellenius et al., 2004 (Wellenius et al., , 2006 . Simultaneous exposure to CO attenuated the effect of PM on the supraventricular arrhythmia rate, but not the frequency of ventricular premature beats. In an epidemiologic study, PM 2.5 and CO were examined for associations with out-of-hospital cardiac arrest during wildfires in Melbourne, Australia (Dennekamp et al., 2015) , but inference about joint effects is weak because analyses were stratified on number of hours people experienced wildfire smoke rather than concentrations of the copollutant.
Other studies observed no consistent combined effect of elevated PM 10 and CO concentrations on CVD effects effect measure modification observed with PM 10 associations on high CO days only in Seoul, Korea (Hong et al., 2002) , and a strong joint effect between PM 10 and CO observed on a Greek peninsula (Kalantzi et al., 2011) .
Overall, the few epidemiologic studies of multipollutant effects of PM and CO represent a mix of effect measure modification (Dennekamp et al., 2015; Hong et al., 2002) or joint effects analyses (Kalantzi et al., 2011) while the experimental studies reported different effects on arrhythmic responses (Wellenius et al., 2004 (Wellenius et al., , 2006 . Epidemiologic and experimental studies examined arrhythmia, cardiovascular hospital admissions or cardiovascular mortality and exposure to either PM 10 , PM 2.5 , or PM 2.5 CAPs making it difficult to assess coherence or consistency across studies.
Ozone and carbon monoxide
Recent assessments provide evidence that short-term exposure to CO or O 3 individually are related to CVD outcomes (U.S. EPA, 2010 (U.S. EPA, , 2013 . Two available epidemiologic studies evaluating the combined effect of CO and O 3 observed associations with CO or O 3 in singlepollutant analyses but have contrasting results regarding a stronger association when concentrations of both CO and O 3 are elevated (Samoli et al., 2007; Kalantzi et al., 2011) . Inference about multipollutant effects is weak from both studies because of potential differential exposure measurement error for CO and O 3 , the stratification by O 3 concentrations at the city level in the multicity European study (Samoli et al., 2007) , or the inadequately described method to analyze joint effects in the Greek Peninsula study (Kalantzi et al., 2011) . , 1997 2001; Chen et al., 2014; Briet et al., 2007; Li et al., 2015; Poursafa et al., 2016; Johannesson et al. 2014; Baja et al., 2012 Baja et al., , 2013 No studies Unclear how to use these studies to inform questions about multipollutant exposures
Cluster studies observed consistent evidence between clusters and CVD endpoints (Park et al., 2007; Grass and Cane, 2008; Mar et al., 2000) Whole atmosphere studies inconsistently associated with CVD effects (Kubesch et al., 2014; Laumbach et al., 2010; Peel et al., 2010; Davoodi et al., 2010) T.J. Luben et al. Environmental Research 161 (2018) 144-152 
Particulate matter and nitrogen dioxide
Information on the multipollutant effects of PM and NO 2 is provided by several epidemiologic studies and one controlled human exposure study. While there is abundant evidence for the relationship between PM 2.5 exposure and CVD endpoints (U.S. EPA, 2009), there is some uncertainty as to whether NO 2 exposure has an effect on CVD endpoints independent from other traffic-related pollutants such as ultrafine particles, CO, elemental carbon/black carbon, and PM 2.5 (U.S. EPA, 2016a) . This may complicate interpretation of the results for PM-NO 2 multipollutant effects.
Evidence integrated from epidemiologic and experimental studies does not provide a clear indication of multipollutant effects of exposure to PM and NO 2 . Among epidemiologic studies, CVD hospital admissions and mortality increase with joint increases in short-and long-term PM and NO 2 concentrations (Kalantzi et al., 2011) , although the elevated risk estimates for long-term concentrations do not indicate joint increases (Crouse et al., 2015; Jerrett et al., 2013) . Epidemiologic evidence shows that higher long-term NO 2 concentrations modify the effect of O 3 and PM 2.5 on CVD hospital admissions (Bobb et al., 2013) but does not show NO 2 or PM 10 to modify each other's association with CVD hospital admissions (Wong et al., 1999; Yu et al., 2013) or stroke mortality (Hong et al., 2002) in a consistent manner. Adding to the uncertainty in drawing inferences from epidemiologic studies is the potential differential measurement error in PM and NO 2 exposure estimates. Similarly, a controlled human exposure study (Huang et al., 2012) of PM 2.5 CAPs collected in Chapel Hill, NC and NO 2 shows both synergistic and antagonistic effects of the combined exposure (evaluated on an additive scale) for an array of endpoints including blood markers, measures of HRV, and myocardial repolarization.
Overall, these studies provide limited evidence of joint effects of PM and NO 2 exposure, although it is not clear that the combined effect is greater than either single-pollutant effect. Further, it is not clear to what extent the multipollutant effect results can be attributable specifically to PM or NO 2 exposure or some other correlated pollutant in epidemiologic studies.
Ozone and nitrogen dioxide
There is evidence for greater than additive CVD mortality increases in relation to joint increases in long-term concentrations of O 3 and NO 2 from epidemiologic studies and conflicting evidence between epidemiologic and controlled human exposure studies for a multipollutant effect on CVD-related morbidity of short-term O 3 and NO 2 exposure. An experimental study provides evidence for a synergistic interaction of NO 2 and O 3 combined exposure on reducing cardiac output (DrechslerParks, 1995) . In epidemiologic studies, no evidence for greater than additive multipollutant effects is indicated for the joint effects of longterm exposure to NO 2 and O 3 on CVD mortality (Jerrett et al., 2013; Crouse et al., 2015) . A limited epidemiologic evidence base inconsistently shows effect measure modification (Weichenthal et al., 2014; Wong et al., 1999; Ponka et al., 1998) . Many uncertainties described in preceding sections weaken inference regarding multipollutant effects of O 3 and NO 2 exposure, including differential exposure measurement error, inconsistent epidemiologic evidence for cardiovascular morbidity related to short-term O 3 exposure, and uncertainty as to whether cardiovascular effects are related to long-term O 3 exposure as well as short-term and long-term NO 2 exposure.
Other two-pollutant combinations
Multipollutant effects of other pollutant combinations were examined in one study for each pollutant combination. Epidemiologic studies reported that associations between short-term increases in ambient SO 2 concentration and mortality from stroke (Hong et al., 2002) and all CVD (Ponka, Savela, and Virtanen, 1998) increased on days with higher PM 10 , O 3 , or NO 2 concentrations (Supplemental Table S8 ). PM 10 -related stroke mortality increased on days with higher SO 2 concentrations (Hong et al., 2002) . In a controlled human exposure study of healthy adults, heart rate increased in response to CO exposure (relative to filtered air exposure) but not in response to exposure to peroxyacetyl nitrate (PAN) alone or in combination with CO (Gliner, Raven, Horvath, Drinkwater, and Sutton, 1975) . PAN is an oxide of nitrogen formed by atmospheric reactions involving NO 2 and organic radicals. These epidemiologic and experimental findings have uncertain implications given the lack of clear evidence linking SO 2 (U.S. EPA, 2008) or PAN exposure to cardiovascular effects.
Air pollution mixtures
Epidemiologic studies examined multipollutant effects on CVD outcomes as diverse air pollution mixtures. Various approaches were used, including whole atmosphere comparisons of locations or time periods with low and high air pollution, indices of predetermined pollutants to represent a specific source or period of higher air pollution, and clusters of days representing varied pollutant combinations. In whole atmosphere studies, cardiovascular effects were not clearly associated with air pollution mixture exposures to high and low traffic environments for adults with regard to heart rate, blood pressure, and blood glucose parameters (Kubesch et al., 2014; Larsson et al., 2007; Laumbach et al., 2010) . Similarly, cardiovascular effects were not associated with air pollution mixtures examined as high and low air pollution days in Atlanta GA (Peel et al., 2010) , or Tehran, Iran (Davoodi et al., 2010) . Some of the inconsistency observed in whole atmosphere studies could be due to the differences in pollutant composition (mainly O 3 and CO versus mainly PM and NO 2 ). Mixture effects were observed in the air pollution index and cluster studies. Indices representing higher air pollution were consistently associated with cardiovascular effects from mortality and emergency department visits to subclinical effects (Baja et al., 2013 (Baja et al., , 2012 Briet et al., 2007; Chen et al., 2014; Li et al., 2015; Peters et al., 1997 Peters et al., , 1999 Poursafa et al., 2016) . In limited analysis, air pollution mixtures characterized by clusters of air mass of similar origin (Park et al., 2007) or air pollutant profiles (Grass and Cane, 2008; Mar et al., 2000) were also associated with CVD outcomes, including subclinical effects and cardiovascular mortality. However, these results do not point to a stronger effect of an air pollution mixture or any single pollutant. Many mixtures analyzed included PM 2.5 , and results are consistent with evidence linking shortterm PM 2.5 exposure to cardiovascular effects. It is not clear how the results should be interpreted or how they might inform joint effects or effect measure modification. While both epidemiologic and experimental studies showed cardiovascular changes in relation to multipollutant exposures, the integrated evidence does not clearly indicate that multipollutant exposures have stronger effects than any single pollutant.
Risk of bias
Risk of bias was evaluated for the epidemiologic and experimental studies included in this review ( Fig. 2 ; Supplemental Tables S6 and S7 ). Because there is limited evidence available on cardiovascular effects of multipollutant exposure, the risk of bias analysis was used to assess confidence in results rather than to eliminate studies from this review. The strongest evidence in epidemiologic studies was for effect measure modification, but several of the studies had probably high risk of bias related to exposure misclassification (Hong et al., 2002; Ponka et al., 1998; Samoli et al., 2007; Yu et al., 2013) , selective reporting of results (Hong et al., 2002; Ponka et al., 1998; Weichenthal et al., 2014) , confounding (Samoli et al., 2007) , or selection of data (Weichenthal et al., 2014) , adding uncertainty to findings. We had greater confidence in effect measure modification observed between PM and O 3 in Wong et al. (1999) because risk of bias was low or probably low across categories. Several of the experimental studies (Drechsler-Parks, 1995; Farraj et al., 2015; Gliner et al., 1975; Huang et al., 2012; Kodavanti et al., 2011; Kurhanewicz et al., 2014; Tankersley et al., 2013; Wagner et al., 2014) had probably high risk of performance bias (mainly due to insufficient information about blinding to study group), and two of these (Farraj et al., 2015; Kodavanti et al., 2011 ) also had probably high risk of selection bias (due to insufficient information on randomization of animals and that treatment and data analyses were blinded). These studies with probably high risk of bias had variable results for cardiovascular effects of multipollutant exposure as did the few experimental studies with low or probably low risk of bias across categories (Brook et al., 2009; Fakhri et al., 2009; Urch et al., 2010; Sivagangabalan et al., 2011; Kusha et al., 2012; Wellenius et al., 2004) . This underscores the need for additional high-quality multipollutant studies.
Strengths and limitations
To our knowledge, this review is the first to survey the epidemiologic and experimental literature on cardiovascular health effects related to exposure to multiple pollutants. Other reviews have identified experimental approaches (Mauderly, 1993; Mauderly and Samet, 2009) or statistical methodologies available to study health effects of multipollutant exposures (Billionnet et al., 2012; Davalos et al., 2016) . The scope of this analysis was necessarily limited to one set of disease outcomes (i.e., cardiovascular disease). However, the small number of peer-reviewed studies on the cardiovascular health effects of exposure to multiple pollutants limits the ability to draw definitive conclusions in a multipollutant framework from this review.
The epidemiologic studies reviewed here form one line of evidence for evaluating cardiovascular effects due to multipollutant exposures. As observational studies, the exposures and participant selection have some biases that could influence interpretation of multipollutant effects. Differential exposure errors among pollutants may result from differences in heterogeneity of the spatial distribution of ambient air pollutants (Goldman et al., 2010) or from differences in instrument accuracy (Dunlea et al., 2007; Kleffmann et al., 2013; Steinbacher et al., 2007; U.S. EPA, 2006; Villena et al., 2012) , and these biases may vary seasonally. These conditions may lead to attenuation of the health effect estimate (Dionisio et al., 2014) . Higher exposure error in one copollutant has been shown to result in a lower effect estimate for that copollutant (Zeger et al., 2000) ; in other words, the copollutant measured with less error may produce a less biased effect estimate.
Experimental studies reviewed here form another line of evidence for evaluating CVD effects due to multipollutant exposures. A wide range of CVD effects were evaluated in a limited number of studies for any given pollutant combination. This makes it difficult to assess coherence for any duration of exposure or specific CVD effect and to reconcile evidence for early biological effects that could lead to more severe CVD health outcomes. At the same time, experimental studies may minimize uncertainty in exposures present in epidemiologic studies since concentration and duration of the pollutant exposures, composition of the air pollutant mixture, method of delivery, breeding of the animal model, and ambient temperature and filtered air control are usually strictly managed. Several studies (Drechsler-Parks, 1995; Gliner et al., 1975; Kodavanti et al., 2011; Tankersley et al., 2013) involve highly reproducible conditions. However, the studies involving exposure to CAPs collected in different geographic locations are dependent on the composition of the ambient PM on any given day or hour and thus are subject to the same real-life variability in exposure conditions as epidemiologic studies (C. D. Sioutas et al., 1995) .
Conclusions
In this review we examined multipollutant effects on an array of CVD outcomes in epidemiologic and experimental studies as joint effects, effect measure modification, or interactions. For completeness and to provide additional context, we also evaluate studies of air pollution mixtures. A broad summary of the results is presented in Table 1 . The largest body of evidence was for PM and O 3 exposure, and when taken together, neither epidemiologic nor experimental studies consistently or coherently indicated a stronger or weaker effect of combined exposure compared with either PM or O 3 exposure alone. Similarly, heterogeneous results were observed across disciplines for other two-pollutant combinations: PM and CO, NO 2 and PM 10 , O 3 and NO 2 , CO and O 3 . Epidemiologic studies of air pollution mixtures did suggest multipollutant effects examined as pollution indices and days clustered by pollutant profile or origin, but not by comparing whole atmospheres. We limited the scope of our study to multipollutant evaluations of CVD, and an important limitation is the paucity of literature on the cardiovascular effects of multipollutant exposures, which limits strong inferences. The experimental literature has shown mixed or synergistic results within a single study, and suffers from a small literature base and heterogeneity in study designs and CVD endpoints examined, which also limit confidence in inferences.
The objective of this review is not to advocate for a singular multipollutant approach that can be practically applied today. Nor are we suggesting that any of the two-pollutant combinations that we evaluate is the key to addressing air pollution policies. Instead, we acknowledge that a multipollutant approach might be valuable to policy makers, and such an approach could focus on PM sources or components, or a combination of pollutants that we have not considered in out review. Our review demonstrates that, relative to the enormous evidence base available for the health effects of individual pollutants, there remains a paucity of evidence to characterize the multipollutant effects of air pollution on health (specifically cardiovascular disease). Our review is a first step in compiling and synthesizing the existing evidence and is not intended to characterize any singular approach that will address multipollutant effects of air pollutants.
Until epidemiologic and experimental studies of multipollutant effects on CVD consistently and coherently provide evidence for a combined effect of two or more pollutants and a health outcome, it will remain implausible to take advantage of any efficiencies a multipollutant regulatory approach might afford. Additional experimental studies of commonly co-occurring pollutants at relevant exposure levels that investigate both early and more downstream biological responses in the CVD continuum of effects are likely to be informative in disentangling multipollutant health effects and setting the course for observational studies. Furthermore, epidemiologic studies of the cardiovascular effects of multipollutant exposure that repeat existing studies at new locations would be especially informative to see if findings can be replicated, particularly for effect measure modification where some positive results have been observed. An expanded body of literature would help to shed light on reasons for seeing stronger effects of O 3 and NO 2 for low PM conditions, particularly by focusing more on the role of PM size. Greater consistency of effect modification findings would also help to counteract concerns about exposure measurement error that have the potential to add bias and uncertainty to health effect estimates. New studies could potentially provide additional evidence for establishing biological plausibility of a synergistic or antagonistic effect, or they could provide more support against those findings. Additional epidemiologic and experimental studies would also allow for better judgment of the coherence between these disciplines.
